NEWS: Medidata Supports Moderna’s COVID-19 Vaccine Clinical Trials with Rave Clinical Cloud Platform

Innovative Patient-Centric Study Design Benefits Study Participants

New York, NY – July 23, 2020 – Medidata, a Dassault Systèmes company, the global leader in creating end-to-end solutions supporting the entire clinical trial process today announced that it is collaborating with Moderna, Inc. (Nasdaq: MRNA) to support clinical trials of mRNA-1273, Moderna’s COVID-19 vaccine candidate.

Medidata’s suite of technologies is supporting the advancement of Moderna’s mRNA-1273 clinical trials, including the Phase 3 trial, which is expected to enroll 30,000 participants. The Medidata and Moderna teams are moving forward with the speed and urgency necessitated by the global pandemic, using Medidata’s innovative and scalable cloud platform for clinical development.

This clinical trial is one of the largest ever to incorporate data capture directly from participants, decreasing the need for office visits. The “virtualization” of the study allows participants to use their own devices if they so choose, easing the burden of having to carry around a separate, provisioned device.     

“We are proud to be working with Moderna on these breakthrough trials, which are so important to medical science and the health of our global society,” said Tarek Sherif, co-founder and co-CEO, Medidata. “The extensive partnership we’ve built together over many years is allowing us to support these critical clinical studies. Clearly, the faster we can arrive at answers, the better it will be for everyone, everywhere.”

“We are pleased to collaborate with Medidata,” said Marcello Damiani, Chief Digital and Operational Excellence Officer, Moderna. “Medidata’s unified platform is helping us put participants at the center of our efforts to develop a safe and effective vaccine against COVID-19.”

Moderna is using a suite of Medidata Rave technologies to help support and accelerate clinical development, including EDC (electronic data capture); eCOA (electronic clinical outcomes assessment), and Detect (centralized statistical monitoring). Moderna has been working with Medidata since December 2015 and the companies have collaborated on multiple clinical trials.

Medidata is a wholly owned subsidiary of Dassault Systèmes, which with its 3DEXPERIENCE platform is positioned to lead the digital transformation of life sciences in the age of personalized medicine with the first end-to-end scientific and business platform, from research to commercialization.


About Medidata

Medidata is leading the digital transformation of life sciences, creating hope for millions of patients. Medidata helps generate the evidence and insights to help pharmaceutical, biotech, medical device and diagnostics companies, and academic researchers accelerate value, minimize risk, and optimize outcomes. More than one million registered users across 1,400 customers and partners access the world's most-used platform for clinical development, commercial, and real-world data. Medidata, a Dassault Systèmes company (Euronext Paris: #13065, DSY.PA), is headquartered in New York City and has offices around the world to meet the needs of its customers. Discover more at www.medidata.com and follow us @Medidata, The Operating System for Life SciencesTM.

Medidata, Rave, and myMedidata are registered trademarks of Medidata Solutions, Inc., a wholly owned subsidiary of Dassault Systèmes.


About Dassault Systèmes

Dassault Systèmes, the 3DEXPERIENCE Company, is a catalyst for human progress. We provide business and people with collaborative virtual environments to imagine sustainable innovations. By creating ‘virtual experience twins’ of the real world with our 3DEXPERIENCE platform and applications, our customers push the boundaries of innovation, learning and production. 

Dassault Systèmes’ 20,000 employees are bringing value to more than 270,000 customers of all sizes, in all industries, in more than 140 countries. For more information, visit www.3ds.com


Original news publication - Dassault Systemes Newsroom

Date - 23rd July, 2020


Share this:

A profile picture for

23rd July

News

Latest Jobs

Architect, Windchill PLM

West Chester, PA, USA Competitive Permanent

Posted on behalf of

Johnson & Johnson

About the job Job DescriptionJohnson & Johnson Technology (JJT), the Enterprise Technology group supporting all business functions under Johnson & Johnson is currently recruiting for an Architect,...

PLM Analyst

Manhattan Beach, CA, USA Competitive Permanent

Posted on behalf of

Fisker

About the job Description: Company Overview Fisker Inc. is a design led pioneering mobility technology company researching, developing and producing next generation electrically power...

Application Consultant - Data Management Solutions

Quakertown, PA, USA Competitive Permanent

Posted on behalf of

Synergis Engineering Design Solutions

About the job Synergis Technologies, the region’s leader in data management, engineering, architectural, civil and manufacturing design solutions is searching for an engineering professional who is...

Looking for people to join your team?

Advertise your role with Momentum PLM. Get Started 

Looking to become a contributor?

Submit an article to Momentum PLM.  Get Involved 

Our Contributors

See the minds behind Momentum PLM.  Learn More 

Meet the Vendors

Read up on the latest vendor updates  Learn More 

Get the latest PLM updates in your inbox

Subscribe to our newsletter

Email Address

*

This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.

By submitting your email address and any other personal information on the website, you consent to it being collected, held, used and disclosed in accordance with our Privacy Policy.

*